chenodeoxycholic acid has been researched along with Chronic Hepatitis B in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iguchi, Y; Inoue, R; Ito, K; Okumura, A; Sakamoto, K; Takeuchi, JS; Umezawa, K; Une, M; Wakita, T; Watashi, K; Yamashita, Y; Yamauchi, T; Yoneda, M | 1 |
| Buchmann, B; Ciesek, S; Döhner, K; Manns, MP; Pinto Marques Souza de Oliveira, C; Sandmann, L; Sarrazin, C; Schlaphoff, V; Sodeik, B; Sprinzl, K; Veloso Alves Pereira, I; von Hahn, T; Vondran, F | 1 |
2 other study(ies) available for chenodeoxycholic acid and Chronic Hepatitis B
| Article | Year |
|---|---|
Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
Topics: Animals; Antiviral Agents; Bile Acids and Salts; Chenodeoxycholic Acid; Cholic Acids; Disease Models, Animal; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Mice; Organic Anion Transporters, Sodium-Dependent; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Receptors, G-Protein-Coupled; Symporters; Transplantation Chimera; Virus Internalization | 2021 |
Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP).
Topics: Adult; Bile Acids and Salts; Carcinoma, Hepatocellular; Cell Line, Tumor; Chenodeoxycholic Acid; Coinfection; Extracellular Space; Female; Gene Expression Regulation, Neoplastic; Hepatitis B, Chronic; Hepatitis D, Chronic; Hepatitis Delta Virus; Humans; Liver Neoplasms; Male; Middle Aged; Organic Anion Transporters, Sodium-Dependent; Sodium; Symporters; Virus Internalization; Virus Replication | 2015 |